Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,448.00 INR | -2.16% |
|
-4.18% | -15.00% |
Capitalization | 1,032B 11.8B 11.45B 10.75B 9.53B 16.9B 18.8B 129B 47.84B 425B 44.25B 43.36B 1,790B | P/E ratio 2025 * |
52.4x | P/E ratio 2026 * | 45.4x |
---|---|---|---|---|---|
Enterprise value | 1,099B 12.57B 12.19B 11.45B 10.15B 18B 20.02B 137B 50.94B 452B 47.12B 46.17B 1,906B | EV / Sales 2025 * |
8.92x | EV / Sales 2026 * | 7.16x |
Free-Float |
22.83% | Yield 2025 * |
0.36% | Yield 2026 * | 0.41% |
Last Transcript: Mankind Pharma Limited
1 day | -2.15% | ||
1 week | -4.18% | ||
Current month | +0.53% | ||
1 month | -5.69% | ||
3 months | -7.50% | ||
6 months | +13.76% | ||
Current year | -15.00% |







Director | Title | Age | Since |
---|---|---|---|
Sheetal Arora
CEO | Chief Executive Officer | 49 | 2007-09-20 |
Ashutosh Dhawan
DFI | Director of Finance/CFO | 56 | 2016-03-02 |
Compliance Officer | 47 | 2025-01-08 |
Manager | Title | Age | Since |
---|---|---|---|
Chairman | 69 | 1991-07-02 | |
Rajeev Juneja
BRD | Director/Board Member | 59 | 1992-12-21 |
Sheetal Arora
BRD | Director/Board Member | 49 | 2007-09-20 |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-2.15% | -4.18% | +10.72% | - | 11.8B | ||
-1.07% | +7.21% | +17.39% | +262.58% | 782B | ||
-1.38% | +2.62% | -26.02% | +79.44% | 378B | ||
+0.73% | +1.56% | -1.61% | -8.96% | 371B | ||
-0.14% | +0.11% | +9.34% | +33.38% | 336B | ||
-0.12% | +1.72% | +29.21% | -18.23% | 256B | ||
-0.20% | +3.92% | +20.05% | +35.47% | 225B | ||
-1.01% | -13.42% | -31.13% | +12.85% | 219B | ||
+0.28% | +0.88% | +9.77% | +20.95% | 210B | ||
+0.43% | +2.05% | +1.26% | +28.83% | 158B | ||
Average | -0.45% | +0.54% | +3.90% | +49.59% | 294.81B | |
Weighted average by Cap. | -0.51% | +2.40% | +4.71% | +88.01% |
2025 * | 2026 * | |
---|---|---|
Net sales | 123B 1.41B 1.37B 1.28B 1.14B 2.02B 2.24B 15.37B 5.71B 50.7B 5.28B 5.17B 214B | 150B 1.72B 1.67B 1.56B 1.39B 2.46B 2.73B 18.73B 6.96B 61.8B 6.44B 6.31B 260B |
Net income | 19.6B 224M 217M 204M 181M 321M 357M 2.45B 908M 8.07B 840M 823M 33.99B | 22.71B 260M 252M 236M 210M 372M 413M 2.83B 1.05B 9.35B 973M 954M 39.38B |
Net Debt | 66.94B 765M 742M 697M 618M 1.1B 1.22B 8.35B 3.1B 27.55B 2.87B 2.81B 116B | 42.61B 487M 473M 444M 393M 698M 776M 5.32B 1.97B 17.54B 1.83B 1.79B 73.9B |
Date | Price | Change | Volume |
---|---|---|---|
25-02-11 | 2,448.00 ₹ | -2.16% | 679,998 |
25-02-10 | 2,502.05 ₹ | -0.66% | 421,865 |
25-02-07 | 2,518.60 ₹ | +1.55% | 630,850 |
25-02-06 | 2,480.10 ₹ | -0.12% | 473,065 |
25-02-05 | 2,483.00 ₹ | -2.82% | 331,196 |
Delayed Quote NSE India S.E., February 11, 2025 at 02:57 am EST
More quotes
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MANKIND Stock